Skip to content
Free shipping and returns
  • About SUDOSCAN®
  • Our Company
  • Medical Articles
  • Approved Cleaning Products
  • Media & Events
  • Contact Us
  • SUDOSCAN® Shop
  • Log in
  • YouTube
  • LinkedIn
Cart
Subtotal
$0.00
Shipping, taxes, and discount codes calculated at checkout.
Your cart is currently empty.
Refundable Security Deposit for Sudoscan Refundable Security Deposit for Sudoscan Sudoscan Logo white Sudoscan Logo white
  • About SUDOSCAN®
  • Our Company
  • Medical Articles
  • Approved Cleaning Products
  • Media & Events
  • Contact Us
  • SUDOSCAN® Shop
account Log in icon-bag-minimalCart
Access Denied
IMPORTANT! If you’re a store owner, please make sure you have Customer accounts enabled in your Store Admin, as you have customer based locks set up with EasyLockdown app. Enable Customer Accounts
Home / Media & Events / The Utility of SUDOSCAN® in Asymptomatic Hepatitis C
Infectious disease · Scientific publications · Feb 18, 2023

The Utility of SUDOSCAN® in Asymptomatic Hepatitis C

Image of Sudoscan's utility in Asymptomatic Hepatitis C

Detection of Small Fiber Neuropathy in Asymptomatic Hepatitis C Virus-Related Cirrhosis Patients Using SUDOSCAN® Technology


ES. Tharwa et al.
Article title: Sudomotor Changes in Hepatitis C Virus Infection with or without Diabetes Mellitus: A Pilot Study in Egyptian Patients.
Am. J. Trop. Med. Hyg., 00(0), 2020, pp. 1–5.

Tharwa et al from Menoufia University, Egypt, conducted a study to evaluate small fiber neuropathy in asymptomatic Hepatitis C virus-related cirrhotic patients with (group 1, n=49) or without diabetes mellitus (group 2, n=48) using the SUDOSCAN test for sweat function assessment.

Peripheral neuropathy was detected in none of the healthy controls, 39% of Hepatitis C virus-related cirrhotic patients without diabetes mellitus, and 62% of Hepatitis C virus -related cirrhotic patients with type 2 diabetes mellitus (P< 0.0001).

Feet electrochemical skin conductance was decreased in group 1 as compared with controls (67 ± 19 versus 88 ± 7 μS, P < 0.0001) and more severely decreased in group 2 (58 ± 19 μS, P = 0.017 as compared with group 1), see Figure 1.

Box-plots of feet electrochemical skin conductance (FESC) in controls, patients with hepatitis C virus (HCV)–related cirrhosis, and patients with HCV-related cirrhosis as well as diabetes mellitus (DM).

Figure 1: Box-plots of feet electrochemical skin conductance (FESC) in controls, patients with hepatitis C virus (HCV)–related cirrhosis, and patients with HCV-related cirrhosis as well as diabetes mellitus (DM).
Feet electrochemical skin conductance is decreased in HCV-related cirrhosis as compared with controls, and more profoundly decreased in patients with DM in addition.

Moreover, a significant correlation was observed between feet Electrochemical skin conductance measured with SUDOSCAN and parameters of increased portal pressure and parameters of increased severity of hepatic dysfunction, see Table 1.

Spearman’s correlations between FESC and parameters of increased portal pressure and severity of hepatic dysfunction

Table 1: Spearman’s correlations between FESC and parameters of increased portal pressure and severity
of hepatic dysfunction

Conclusion: Electrochemical skin conductance measurement is a valuable, noninvasive method for early detection of small fiber neuropathy in asymptomatic Hepatitis C virus-related cirrhosis, with or without diabetes mellitus.

Share Share on Facebook Share Tweet on X Pin it Pin on Pinterest

icon-left-arrow Back to Media & Events
Invalid password
Enter
Sudoscan Logo

SUDOSCAN® is a privately-owned French medical device company.

Created in June 2005, SUDOSCAN is located in San Diego, CA, USA; the company's corporate headquarters are in Paris, France. We service all of the North and South America, The Middle East, Europe and Asia.

  • YouTube
  • LinkedIn

Sudoscan

  • About SUDOSCAN®
  • Our Company
  • Medical Articles
  • Approved Cleaning Products
  • Media & Events
  • Contact Us
  • SUDOSCAN® Shop

Shop SUDOSCAN

  • Login
  • Create account
  • SUDOSCAN® Shop

Resources

  • For Physicians
  • Reimbursement Regulatory
  • Approved Cleaning Products
  • For Patients
  • SUDOSCAN® Videos
  • SUDOSCAN® Image Gallery
  • SUDOSCAN® Articles

CONTACT INFO:

US TERRITORIES:
SUDOSCAN Inc.
8525 Gibbs Dr. Suite 304
San Diego, CA 92123

Phone: +1 858 450 2800

INTERNATIONAL:
Impeto Medical
2 Rue Maurice Hartmann,
92130 Issy-les-Moulineaux,
France

Phone: +33 (0)7 87 20 32 03
Website: www.sudoscan.com

Promotional Communication. The medical devices SUDOSCAN® is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 05/10/2023

  • American Express
  • Diners Club
  • Discover
  • Mastercard
  • Visa
© 2025 SUDOSCAN USA | Autonomic & Sudomotor Testing Device Powered by Shopify
The Utility of SUDOSCAN® in asymptomatic Hepatitis C.